Chief Accounting Officer
Autolus Therapeutics plc (AUTL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Rob Dolski is recorded as Chief Accounting Officer at Autolus Therapeutics plc (AUTL). Autolus Therapeutics plc reported in an 8-K filed April 3, 2025 that Rob Dolski was appointed principal accounting officer, effective April 3, 2025. Rob Dolski has spoken on 2 earnings calls across 1 company, most recently for Autolus Therapeutics plc on August 12, 2025.
“On April 3, 2025, the Board of Directors of the Company appointed Rob Dolski, the Company's current Chief Financial Officer, to serve as the principal accounting officer of the Company in addition to his current role as principal financial officer, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2025-04-03–present
Recorded roles and call appearances connecting this person to public companies.
Chief Accounting Officer
2025-04-03–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
